News & nuggets
Virus & vaccine
At the end of February, the Food & Drug Administration approved Johnson & Johnson single use coronavirus vaccine for emergency use in the U.S. Along with increasing production of the Pfizer and Moderna vaccines, the supply of vaccines is expected to grow significantly by spring.
The U.S. has been averaging 1.7 million vaccines administered per day over the last 7 days. In the U.S., more individuals have received at least one dose than have tested positive for COVID. As of the end of February, approximately 50 million Americans (~15% of the population) had received the first shot with approximately 25 million having received the second as well.
Minutes from the Federal Open Market Committee January 26-27 meeting contained few surprises. The Fed noted their improving medium term outlook given progress on vaccines and the December stimulus. While inflation has been a growing topic, the minutes showed most Fed members were more concerned regarding the risks of low inflation.
Outlook and conclusions
All investments involve risk, including the possible loss of principal.
This is not intended to serve as a complete analysis of every material fact regarding any company, industry or security. The opinions expressed here reflect our judgment at this date and are subject to change. Information has been obtained from sources we consider to be reliable, but we cannot guarantee the accuracy. This publication is prepared for general information only. This material does not constitute investment advice and is not intended as an endorsement of any specific investment. It does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this report. Investors should seek advice regarding the appropriateness of investing in any securities or investment strategies discussed or recommended in this report and should understand that statements regarding future prospects may not be realized. Investment involves risk. Market conditions and trends will fluctuate. The value of an investment as well as income associated with investments may rise or fall. Accordingly, investors may receive back less than originally invested. Investments cannot be made in an index. Past performance is not necessarily a guide to future performance.